No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ENTX Entera Bio
- 2.1600
- +0.0700+3.35%
Close May 3 16:00 ET
- 2.0590
- -0.1010-4.68%
Post 16:30 ET
76.64MMarket Cap-6967P/E (TTM)
2.2000High2.0200Low235.45KVolume2.0800Open2.0900Pre Close497.52KTurnover0.95%Turnover RatioLossP/E (Static)35.48MShares3.350052wk High7.37P/B53.76MFloat Cap0.520052wk Low--Dividend TTM24.89MShs Float10.1600Historical High--Div YieldTTM8.61%Amplitude0.4722Historical Low2.1130Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Entera Bio Ltd. (ENTX) Stock Slides as Market Rises: Facts to Know Before You Trade
Why the Market Dipped But Entera Bio Ltd. (ENTX) Gained Today
Veru, Theravance Biopharma, Adial Pharmaceuticals Among Healthcare Movers
Is Entera Bio (ENTX) Outperforming Other Medical Stocks This Year?
Entera Bio Announces Publication of Oral PTH(1-34) Peptide Tablets (EB613) Phase 2 Trial Data in the Journal of Bone and Mineral Research
JERUSALEM, April 08, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), ("Entera" or the "Company") a leader in the development of orally delivered peptides, announced today that data from the Phase 2 Trial of its
Entera Bio Is Maintained at Buy by HC Wainwright & Co.
Entera Bio Is Maintained at Buy by HC Wainwright & Co.
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg